Verition Fund Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Sell |
28,928
-13,521
| -32% | -$933K | 0.01% | 1447 |
|
|
2025
Q1 | $2.95M | Buy |
42,449
+36,830
| +655% | +$2.56M | 0.01% | 1014 |
|
|
2024
Q4 | $483K | Sell |
5,619
-45,603
| -89% | -$3.92M | ﹤0.01% | 1906 |
|
|
2024
Q3 | $6.1M | Buy |
51,222
+49,720
| +3,310% | +$5.92M | 0.03% | 569 |
|
|
2024
Q2 | $214K | Sell |
1,502
-243
| -14% | -$34.7K | ﹤0.01% | 1911 |
|
|
2024
Q1 | $224K | Sell |
1,745
-1,001
| -36% | -$129K | ﹤0.01% | 1848 |
|
|
2023
Q4 | $284K | Buy |
+2,746
| New | +$284K | ﹤0.01% | 1415 |
|
|
2020
Q1 | – | Sell |
-25,212
| Closed | -$730K | – | 810 |
|
|
2019
Q4 | $730K | Buy |
+25,212
| New | +$730K | 0.01% | 447 |
|
|
2018
Q4 | – | Sell |
-72,784
| Closed | -$1.72M | – | 1035 |
|
|
2018
Q3 | $1.72M | Buy |
72,784
+59,916
| +466% | +$1.41M | 0.06% | 331 |
|
|
2018
Q2 | $297K | Buy |
12,868
+4,042
| +46% | +$93.3K | 0.02% | 794 |
|
|
2018
Q1 | $217K | Buy |
+8,826
| New | +$217K | 0.02% | 922 |
|
|
2017
Q4 | – | Sell |
-9,732
| Closed | -$234K | – | 1062 |
|
|
2017
Q3 | $234K | Sell |
9,732
-21,500
| -69% | -$517K | 0.02% | 933 |
|
|
2017
Q2 | $670K | Buy |
+31,232
| New | +$670K | 0.07% | 269 |
|
|
2017
Q1 | – | Sell |
-36,370
| Closed | -$652K | – | 1284 |
|
|
2016
Q4 | $652K | Sell |
36,370
-34,926
| -49% | -$626K | 0.06% | 373 |
|
|
2016
Q3 | $1.48M | Buy |
71,296
+62,124
| +677% | +$1.29M | 0.16% | 102 |
|
|
2016
Q2 | $247K | Buy |
+9,172
| New | +$247K | 0.03% | 598 |
|